Skip to content

Clinical trials

Erectile Dysfunction trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Erectile Dysfunction Country / region: Russia Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20052
20091
20102
20131
20151
20171
20182
20201
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Unknown status4
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3
Bayer2
Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation1
Eli Lilly and Company1
Futura Medical Developments Ltd.1
I.M. Sechenov First Moscow State Medical University1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Lomonosov Moscow State University Medical Research and Educational Center1
N.N. Petrov National Medical Research Center of Oncology1
Research Center, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Erectile Dysfunction15
Atherosclerosis1
Cardiovascular Diseases1
Coronary Artery Disease1
Impotence, Vasculogenic1
Premature Ejaculation1
Prostatic Hyperplasia1
Sexual Dysfunction, Physiological1

Trials

Showing 51 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.